DexCom Analyst Price Targets - Benzinga

SPY767.15−1.40%QQQ722.10−2.89%BTC/USD81,698.22+0.16%DIA515.55−0.13%GLD376.92−1.24%TLT79.02+0.83%

DexCom Inc

DXCMNASDAQ

Trade with Public

Trade with Public

$83.47

-1.59-1.87%

Last update: Oct 14, 4:03 PM

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Connect With Us

About Benzinga

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

DexCom Analyst Price Targets - Benzinga

DexCom Analyst Price Targets

Wall Street analyst price targets and consensus rating for DexCom (DXCM).

Price Target Range — 9 Quarters

Analyst Consensus — 26 Analysts

1S.Buy

23Buy

2Hold

Consensus RatingBuy# Analysts26Avg. Consensus PT$91Upside to Avg. PT+9.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 12, 2026	BTIG	Ryan Zimmerman	PT Raise	Buy	$90→$96
Oct 7, 2026	Barclays	Christopher Pasquale	Initiate	Overweight	$115
Oct 1, 2026	RBC Capital	Kendall Au	PT Raise	Outperform	$90→$105
Sep 18, 2026	Truist Securities	Richard Newitter	PT Raise	Buy	$93→$102
Sep 18, 2026	TD Cowen	Joshua Jennings	Maintained	Buy	$95
Aug 4, 2026	Argus Research	Steve Silver	PT Raise	Buy	$86→$96
Aug 3, 2026	Canaccord Genuity	William Plovanic	PT Raise	Buy	$82→$90
Jul 31, 2026	Citigroup	Joanne Wuensch	PT Raise	Buy	$84→$88
Jul 31, 2026	RBC Capital	Kendall Au	PT Raise	Outperform	$85→$90
Jul 31, 2026	Mizuho	Anthony Petrone	PT Raise	Outperform	$90→$95
Jul 31, 2026	JP Morgan	Robbie Marcus	PT Raise	Neutral	$65→$82
Jul 31, 2026	Piper Sandler	Matt O'Brien	PT Raise	Overweight	$88→$95
Jul 31, 2026	Wells Fargo	Larry Biegelsen	PT Raise	Overweight	$85→$90
Jul 31, 2026	Stifel	Jonathan Block	PT Raise	Buy	$90→$95
Jul 31, 2026	Benchmark	Bruce D. Jackson	PT Raise	Buy	$77→$82
Jul 31, 2026	Truist Securities	Richard Newitter	PT Raise	Buy	$87→$93
Jul 31, 2026	BTIG	Marie Thibault	PT Raise	Buy	$80→$90
Jul 28, 2026	UBS	Patrick Wood	Reinstates	Buy	$96
Jul 16, 2026	Truist Securities	Richard Newitter	PT Raise	Buy	$80→$87
Jul 15, 2026	Mizuho	Anthony Petrone	PT Raise	Outperform	$85→$90

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
BTIG Maintains Buy on DexCom, Raises Price Target to $96

BTIG analyst Ryan Zimmerman maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $90 to $96.

Benzinga Newsdesk

PRO
Barclays Initiates Coverage On DexCom with Overweight Rating, Announces Price Target of $115

Barclays analyst Christopher Pasquale initiates coverage on DexCom (NASDAQ:DXCM) with a Overweight rating and announces Price Target of $115.

Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on DexCom, Raises Price Target to $105

RBC Capital analyst Kendall Au maintains DexCom (NASDAQ:DXCM) with a Outperform and raises the price target from $90 to $105.

Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on DexCom, Raises Price Target to $102

Truist Securities analyst Richard Newitter maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $93 to $102.

Benzinga Newsdesk

PRO
TD Cowen Reiterates Buy on DexCom, Maintains $95 Price Target

TD Cowen analyst Joshua Jennings reiterates DexCom (NASDAQ:DXCM) with a Buy and maintains $95 price target.

Benzinga Newsdesk

PRO
Argus Research Maintains Buy on DexCom, Raises Price Target to $96

Argus Research analyst Steve Silver maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $86 to $96.

Benzinga Newsdesk